HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sandra Donnini Selected Research

Cyclin-Dependent Kinase Inhibitor p21

1/2016Studying Vascular Angiogenesis and Senescence in Zebrafish Embryos.
1/2013Assessing vascular senescence in zebrafish.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sandra Donnini Research Topics

Disease

32Neoplasms (Cancer)
07/2022 - 01/2003
7Hypoxia (Hypoxemia)
01/2021 - 07/2002
5Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2021 - 05/2017
5Cerebral Amyloid Angiopathy (Congophilic Angiopathy)
11/2020 - 07/2010
5Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2012 - 11/2004
4Alzheimer Disease (Alzheimer's Disease)
11/2020 - 12/2004
4Colonic Neoplasms (Colon Cancer)
08/2018 - 08/2010
3Breast Neoplasms (Breast Cancer)
01/2020 - 12/2018
3Pathologic Processes
01/2020 - 01/2004
3Neoplasm Metastasis (Metastasis)
01/2015 - 03/2007
2Melanoma (Melanoma, Malignant)
07/2022 - 12/2019
2Lung Neoplasms (Lung Cancer)
01/2021 - 01/2019
2Inflammation (Inflammations)
01/2018 - 06/2015
2Edema (Dropsy)
01/2018 - 01/2003
2Prostatic Neoplasms (Prostate Cancer)
07/2016 - 08/2015
2Cardiovascular Diseases (Cardiovascular Disease)
03/2016 - 03/2010
2Stroke (Strokes)
01/2013 - 04/2009
1Metabolic Syndrome (Dysmetabolic Syndrome X)
05/2020
1Vascular Diseases (Vascular Disease)
03/2020
1Cancer Pain
01/2020
1B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2020
1Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2020
1Neurodegenerative Diseases (Neurodegenerative Disease)
01/2020
1Pain (Aches)
01/2020
1Retinal Neovascularization
01/2018
1Retinal Diseases
01/2018
1Frailty
01/2018
1Atherosclerosis
01/2018
1Hypertension (High Blood Pressure)
01/2018
1Adenocarcinoma of Lung
05/2017
1Heart Failure
03/2016

Drug/Important Bio-Agent (IBA)

11Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2021 - 07/2002
9ErbB Receptors (EGF Receptor)IBA
01/2019 - 11/2004
7Proteins (Proteins, Gene)FDA Link
07/2022 - 04/2008
7ProstaglandinsIBA
06/2017 - 01/2008
6EnzymesIBA
07/2022 - 11/2003
5Amyloid (Amyloid Fibrils)IBA
11/2020 - 12/2004
5Olive OilIBA
05/2020 - 08/2010
5Prostaglandins EIBA
01/2019 - 01/2008
5Dinoprostone (PGE2)FDA Link
01/2019 - 08/2007
5Peptides (Polypeptides)IBA
01/2016 - 11/2003
4PolyphenolsIBA
03/2020 - 08/2010
4Prostaglandin-E SynthasesIBA
01/2019 - 08/2010
4Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
01/2018 - 12/2004
4Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2018 - 01/2004
33,4-dihydroxyphenylethanol (hydroxytyrosol)IBA
03/2020 - 03/2016
3Phosphotransferases (Kinase)IBA
03/2018 - 08/2010
3Epidermal Growth Factor (EGF)IBA
03/2018 - 06/2017
3Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
06/2017 - 07/2002
3Amyloid beta-PeptidesIBA
07/2010 - 12/2004
2AldehydesIBA
07/2022 - 12/2019
2Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
01/2021 - 07/2002
2AntioxidantsIBA
03/2020 - 03/2016
2Cyclooxygenase 2 (Cyclooxygenase-2)IBA
12/2019 - 08/2007
2Tretinoin (Retinoic Acid)FDA LinkGeneric
01/2019 - 12/2018
2Protein Isoforms (Isoforms)IBA
01/2019 - 10/2002
2Messenger RNA (mRNA)IBA
08/2018 - 07/2002
2Cadherins (E-Cadherin)IBA
08/2018 - 06/2017
2Pharmaceutical PreparationsIBA
03/2016 - 01/2016
2Antineoplastic Agents (Antineoplastics)IBA
03/2016 - 01/2003
2Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
03/2016 - 03/2010
2Cyclin-Dependent Kinase Inhibitor p21IBA
01/2016 - 01/2013
2GalactosidasesIBA
01/2016 - 01/2013
2Nitric Oxide Synthase (NO Synthase)IBA
08/2007 - 10/2002
2pyrimidineIBA
03/2007 - 11/2004
2src-Family KinasesIBA
03/2007 - 11/2004
2Angiogenesis InhibitorsIBA
03/2007 - 07/2004
1Neutralizing AntibodiesIBA
07/2022
1Membrane Proteins (Integral Membrane Proteins)IBA
11/2020
1Sulfates (Sulfates, Inorganic)IBA
03/2020
1Morphine (MS Contin)FDA LinkGeneric
01/2020
1Opioid Analgesics (Opioids)IBA
01/2020
1Opioid Receptors (Opioid Receptor)IBA
01/2020
1Rituximab (Mabthera)FDA Link
01/2020
1Oxidoreductases (Dehydrogenase)IBA
12/2019
1IsoenzymesIBA
12/2019
1Gefitinib (Iressa)FDA Link
01/2019
13' Untranslated Regions (3' UTR)IBA
01/2019
1Tyrosine Kinase InhibitorsIBA
01/2019
1RNA (Ribonucleic Acid)IBA
01/2019
1Aldehyde DehydrogenaseIBA
12/2018
1tyrosine receptor (receptor, tyrosine)IBA
03/2018
1Dynamins (Dynamin)IBA
03/2018
1CytokinesIBA
01/2018
1Oxygen (Dioxygen)IBA
01/2018
1Retinaldehyde (Retinal)IBA
01/2018
1BradykininIBA
01/2018
1KallidinIBA
01/2018
1Cetuximab (Erbitux)FDA Link
10/2017
1VimentinIBA
06/2017
1Tyrosine (L-Tyrosine)FDA Link
05/2017
1LigandsIBA
05/2017
1LectinsIBA
04/2017
1MicroRNAs (MicroRNA)IBA
07/2016
1Nitric Oxide DonorsIBA
03/2016
1Protective AgentsIBA
03/2016

Therapy/Procedure

8Therapeutics
01/2021 - 01/2003
3Drug Therapy (Chemotherapy)
12/2021 - 03/2016
1Immunotherapy
01/2021
1Lasers (Laser)
04/2017